Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dolatav: Dolutegravir + Atazanavir/r in HIV-1 with Detectable Viremia
NCT02542852Phase 2Completed
- Sponsor
- Antonella Castagna
- Start
- Sep 2015
- Primary completion
- Jun 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of dolutegravir, atazanavir in human immunodeficiency virus type 1 infection (HIV-1), sponsored by Antonella Castagna. Started Sep 2015; status: completed.
02
Drugs
dolutegraviratazanavir
03
Conditions
human immunodeficiency virus type 1 infection (HIV-1)
Beyond the preview
Go deeper on NCT02542852.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02542852.